Angela Hwang - 23 Feb 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role
Group President
Signature
Susan E. Grant, by power of atty., for Angela Hwang
Issuer symbol
PFE
Transactions as of
23 Feb 2022
Net transactions value
-$150,813
Form type
4
Filing time
25 Feb 2022, 17:10:12 UTC
Previous filing
15 Nov 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $583,955 +21,359 $27.34 21,359 23 Feb 2022 Direct F1
transaction PFE Common Stock Tax liability $192,636 -4,110 -19% $46.87 17,249 23 Feb 2022 Direct F2
transaction PFE Common Stock Tax liability $542,132 -10,572 -61% $51.28 6,677 23 Feb 2022 Direct F3, F4
holding PFE Common Stock 27,835 23 Feb 2022 By Rule 16b-3 Plan
holding PFE Common Stock 8,532 23 Feb 2022 By Spouse F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -21,359 -100% $0.000000* 0 23 Feb 2022 Common Stock 21,359 $27.34 Direct
transaction PFE Stock Appreciation Rights Award $0 +95,095 $0.000000 95,095 24 Feb 2022 Common Stock 95,095 $45.96 Direct F6
transaction PFE Stock Appreciation Rights Award $0 +83,637 $0.000000 83,637 24 Feb 2022 Common Stock 83,637 $45.96 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F5 The reporting person disclaims beneficial ownership of the shares held by spouse.
F6 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F7 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.